FDA’s approval of Bristol Myers Squibb’s Breyanzi as the first CAR T therapy for relapsed or refractory marginal zone ...
The agency’s decision is based on claims that the Covid vaccine was linked to the deaths of 10 children.
Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and ...
Along with the deployment and integration the new agentic AI tool, FDA is also launching an agentic AI challenge for its ...
In today’s Pharmaceutical Executive Daily, the FDA appoints Tracy Beth Høeg as acting CDER director, health systems explore ...
Dr. Pazdur’s decision comes just weeks after being appointed as the head of CDER earlier in November this year.His ...
New data shows that China and the US dominate breast cancer clinical trial expertise while lower-income countries remain ...
How has the rise of GLP-1s impacted businesses outside of pharma? Jay Bregman: Up until, the rise of these medications has ...
Eli Lilly has announced a price reduction for Zepbound single-dose vials, targeting improved affordability for self-pay ...
The main takeaway is that GLP-1s appear to provide kidney protection in a specific, well-defined population, CKD driven by ...
Layoffs are looming in Switzerland as Novartis announces its plans to cut upwards of 550 full-time positions by the end of ...
Regeneron announced that it has entered into a global collaboration agreement with Tessera Therapeutics to commercialize and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results